Skip to content
Home
About Us
History, Business Model & Mission
Quality Statement
Management Team
Careers
CRO Services
Focus Expertise & Approach
Expertise in Delivery Routes
Ophthalmic Drug Delivery
Injectable Drug Delivery
Rectal Drug Delivery
Transdermal Drug Delivery
Sublingual Drug Delivery
Oral Drug Delivery
Intranasal Drug Delivery
Inhalation Drug Delivery
Otic Drug Delivery
Expertise in Analytics
Facilities & Capabilities
Pharmaceutical Testing Services
Collaborations
Lipid Nanoparticles (LNP)
Cyclodextrins
Microencapsulation
Nano- & Micro-Crystallization
Licensable Technologies
NanoM Wafer™ Ocular Insert
OcuHeal™ LNP
Capability Statement
Newsroom
Publications
Press Releases
White Papers
Newsletters
Blog
Contact
Home
About Us
History, Business Model & Mission
Quality Statement
Management Team
Careers
CRO Services
Focus Expertise & Approach
Expertise in Delivery Routes
Ophthalmic Drug Delivery
Injectable Drug Delivery
Rectal Drug Delivery
Transdermal Drug Delivery
Sublingual Drug Delivery
Oral Drug Delivery
Intranasal Drug Delivery
Inhalation Drug Delivery
Otic Drug Delivery
Expertise in Analytics
Facilities & Capabilities
Pharmaceutical Testing Services
Collaborations
Lipid Nanoparticles (LNP)
Cyclodextrins
Microencapsulation
Nano- & Micro-Crystallization
Licensable Technologies
NanoM Wafer™ Ocular Insert
OcuHeal™ LNP
Capability Statement
Newsroom
Publications
Press Releases
White Papers
Newsletters
Blog
Contact
Search
Publications
Publications
ARVO 2026 OcuHeal UV400
An UV-Blocking Antioxidant Product to Protect Ocular Tissues from UV Damage and Modulate Healing, ARVO 2025
NEW PRODUCT OPPORTUNITY OcuHeal™-UV400+
Delivery of a PPAR Agonist via a Biodegradable Ocular Insert to Achieve Scar-Free Corneal Wound Healing, ARVO2019
Sustained Release of Small, Hydrophilic Peptides to the Ocular Surface via NanoM™, ARVO2018
Sustained Release Micro-Encapsulates to Administer Highly Water-Soluble Peptides for Retinal Diseases, CRS2017
A Novel Biocompatible, Membrane-Interactive Delivery System for Administration of Ophthalmic Anti-inflammatory Drugs, ARVO2016
Sustained Release Micro-Encapsulates to Administer Peptides, Proteins and Nucleic Acids for Retinal Diseases, ARVO2014
ARVO 2026 OcuHeal UV400 Press Release
Delivery of Proteins to the Ocular Surface via NanoM-Wafer DDS, ARVO 2025
Sustained Delivery of Proteins to the Ocular Surface via a Mucoadhesive Delivery System, NanoM™, ARVO2019
Development of a Highly Bioavailable, Sustained Release Nanocore-based (OcuSurf™) Ophthalmic Formulation for the Treatment of Blepharitis, ARVO2018
Sustained Release Micro-Encapsulates to Administer Highly Water-Soluble Peptides for Retinal Diseases, CRS2017
Sustained Drug Delivery to the Posterior Segments of the Eye, OnDrugDelivery 2015
Single Administration Sustained Release Formats for Delivery of Ophthalmic Medications to the Ocular Surface, Cornea and Anterior Chamber, ARVO2014
ARVO 2026 NanoM Wafer Proteins Peptides and Small Molecules 42926
NanoM Wafer™ Biomimetic Lubricating Bandage
Delivery of a PPAR Agonist via a Biodegradable Ocular Insert to Achieve Scar-Free Corneal Wound Healing, ARVO2019
A Bioavailable, Sustained Release Nanocore (Ocusurf™) Brinzolamide Drug Product for Glaucoma Therapy, Compared to Azopt™, ARVO2018
A Novel Biocompatible, Membrane-Interactive Delivery System for Administration of an Antimicrobial to Treat MRSA, CRS2017
A Novel, Non-Invasive, Self-Administered, Preservative-Free, Sustained Release Product (EySite-NanoM™-TP) for Glaucoma Therapy, ARVO2015
Ocular Drug Delivery: Review of Present Technologies & Steps Forward, 2014
ARVO 2026 NanoM Wafer Artificial Tear Film 42826
A Biomimetic Dissolvable Artificial Tear Insert to Replenish Lipid and Aqueous Tear Components, ARVO 2025
Efficient Delivery of a Hydrophobic PPAR Agonist OS300 via a Nanostructured Delivery System, for the Treatment of Meibomian Gland Dysfunction, ARVO2019
Sustained Release of Peptides to the Ocular Surface via NanoM™ Wafer, ARVO2017
Introducing OcuSurf™ Nanostructured Emulsion as a 505(b)(2) Strategy, OnDrugDelivery 2016
OcuSurf™: A Nanostructured, Membrane-Interactive, Biphasic Ocular Drug Delivery System for Once/Day Administration of Water-Insoluble Ophthalmic Medications, ARVO2014
Healthcare CRO Innovative Drug Delivery, CEOCFO Magazine 2013
